Naofumi Takamatsu

Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer

Suyoun Chung, Hanae Suzuki, Takashi Miyamoto et al. · Oncotarget · 2012 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17

T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer

Yuji Ikeda, Jae‐Hyun Park, Takashi Miyamoto et al. · Clinical Cancer Research · 2016 · 87 citations

Medicine, Oncology, Pharmacology +16

Organization and structure of hox gene loci in medaka genome and comparison with those of pufferfish and zebrafish genomes

Gene Kurosawa, Naofumi Takamatsu, Masayoshi Takahashi et al. · Gene · 2006 · 59 citations

Life Sciences, Genetics, Molecular Genetics +13

Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma

Shingo Nakahata, Yusuke Saito, Kousuke Marutsuka et al. · Leukemia · 2012 · 52 citations

Medicine, Hematology, Oncology +9

Critical Role for TSLC1 Expression in the Growth and Organ Infiltration of Adult T-Cell Leukemia Cells In Vivo

Md. Zahidunnabi Dewan, Naofumi Takamatsu, Tomonori Hidaka et al. · Journal of Virology · 2008 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +12